COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges

類似資料

• A Machine Learning Model Accurately Predicts Ulcerative Colitis Activity at One Year in Patients Treated with Anti-Tumour Necrosis Factor α Agents
  著者:: Popa, Iolanda Valentina, 等
  出版事項: (2020)
• What is the impact of age on adult patients with inflammatory bowel disease?
  著者:: PRELIPCEAN, CRISTINA CIJEVSCHI, 等
  出版事項: (2013)
• The specialized educational and psychological counseling in inflammatory bowel disease patients – a target or a challenge?
  著者:: Gavrilescu, Otilia, 等
  出版事項: (2020)
• Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania
  著者:: Dumitrescu, Gabriela, 等
  出版事項: (2014)
• Magnesium—A Potential Key Player in Inflammatory Bowel Diseases?
  著者:: Georgiana-Emmanuela Gilca-Blanariu, 等
  出版事項: (2022-05-01)